NIPT is a non-invasive test that detects genetic conditions such as Down, Edwards, and Patau syndrome, from as early as week 10 of pregnancy.NIPT detects genetic abnormalities caused by additional or missing genetic information in the child’s DNA. The test can be performed from week 10 of pregnancy. It’s a non-invasive test requiring only 10 ml of blood from the mother’s arm. Available from week 10 of pregnancy. The test analyses cell-free DNA fragments present in mother’s blood.Cell-free DNA (cfDNA) are short fragments of DNA found in the bloodstream. During pregnancy, the mother’s blood contains both her and her fetus’ cell-free DNA. Our own laboratory in Europe allows us to perform the analysis according to the highest standards, and to maintain full control over quality and procedures (accuracy, security).We analyse the data and determine the presence of genetic abnormalities. State-of-the-art genetic sequencing technology and advanced bioinformatics algorithms allow us to analyse cell-free DNA in the mother’s blood. We identify potential chromosomal abnormalities of the fetus by counting particular chromosomes. If an abnormality is present, we detect small excesses or deficits in counts of the affected chromosome.